NCT02346565

Brief Summary

The overall question the investigators would like to help answer is whether SE with or without MCE data can be widely used as a first line investigation in women with no previous history of Coronary Artery Disease (CAD) who present with chest pain of recent onset. In order to answer this question the investigators will look at the following: i) Is SE superior to ExECG in terms of cost to diagnosis and negative predictive value of CAD? ii) What is the additive value of myocardial perfusion data to wall motion data for predicting significant CAD on angiography and future cardiac events in women? iii) What is the additive value of Carotid ultrasonography in a large population of women referred for stress testing?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
416

participants targeted

Target at P50-P75 for not_applicable coronary-artery-disease

Timeline
Completed

Started Jan 2015

Longer than P75 for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

January 14, 2015

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 27, 2015

Completed
7.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

October 20, 2022

Status Verified

April 1, 2022

Enrollment Period

7.7 years

First QC Date

January 14, 2015

Last Update Submit

October 17, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Comparison of Positive Predictive Value of each test for Coronary artery disease detection

    To compare positive predictive value of each test for the detection of obstructive CAD defined as ≥ 70% luminal diameter narrowing in one or more epicardial coronary arteries or their major branches during invasive coronary arteriography

    2 years

  • To compare the use of Downstream resource utilisation following allocated functional tests

    Comparison between the number of follow-up investigations, clinic visits and hospitalisation for patients in the 2 test groups.

    2 years

Study Arms (2)

Exercise ECG

OTHER

Patients will undergo an exercise test using the standard Bruce protocol. Standard end points of exercise testing will include: fatigue, severe ischaemia (severe chest pain, \>2mm ST depression on ECG), hypertension (systolic BP\>220mmHg), hypotension, pre-syncope or arrhythmia.

Procedure: Exercise ECG

Stress Echocardiography

OTHER

A two-dimensional echocardiogram will be performed in the lateral decubitus position. Digitized images of the left ventricle (LV) will be obtained in the parasternal long-axis, short-axis, and apical four-, two-, and three-chamber views. In the case of exercise stress echo, images will be acquired at rest and immediately (within 90 seconds) after peak exercise. In the case of dobutamine stress echo, images will be acquired at rest, at the end of stage one of dobutamine administration (10mcg/Kg/min) and at peak stress.

Procedure: Stress Echocardiography

Interventions

Exercise ECGPROCEDURE
Exercise ECG
Stress Echocardiography

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 30 years and above
  • No previous history of Coronary Artery Disease
  • Chest pain of presumed cardiac origin, which has occurred in the last month prior to the clinic appointment.

You may not qualify if:

  • Electrocardiogram diagnostic of cardiac ischaemia and/or infarction (ST-segment deviations\>0.5mm, or T-wave inversion).
  • Previous history of Coronary Artery Disease
  • Chest pain in the last 24 hours
  • Inability to provide informed consent
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwick Park Hospital

Harrow, Middx, HA1 3UJ, United Kingdom

Location

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 14, 2015

First Posted

January 27, 2015

Study Start

January 1, 2015

Primary Completion

September 1, 2022

Study Completion

September 1, 2022

Last Updated

October 20, 2022

Record last verified: 2022-04

Locations